FDA Approves Rucaparib as Maintenance Therapy for Ovarian Cancer FDA Approves Rucaparib as Maintenance Therapy for Ovarian Cancer

The new FDA action does not require biomarker testing prior to prescribing.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news